Chu Q - Search Results

1

Developing TRAIL/TRAIL death receptor-based cancer therapies.

Yuan X, Gajan A, Chu Q, Xiong H, Wu K, Wu GS. Yuan X, et al. Among authors: chu q. Cancer Metastasis Rev. 2018 Dec;37(4):733-748. doi: 10.1007/s10555-018-9728-y. Cancer Metastasis Rev. 2018. PMID: 29541897 Free PMC article. Review.

2

DACH1 inhibits cyclin D1 expression, cellular proliferation and tumor growth of renal cancer cells.

Chu Q, Han N, Yuan X, Nie X, Wu H, Chen Y, Guo M, Yu S, Wu K. Chu Q, et al. J Hematol Oncol. 2014 Oct 17;7:73. doi: 10.1186/s13045-014-0073-5. J Hematol Oncol. 2014. PMID: 25322986 Free PMC article.

3

Notch signaling and EMT in non-small cell lung cancer: biological significance and therapeutic application.

Yuan X, Wu H, Han N, Xu H, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: chu q. J Hematol Oncol. 2014 Dec 5;7:87. doi: 10.1186/s13045-014-0087-z. J Hematol Oncol. 2014. PMID: 25477004 Free PMC article. Review.

4

DACH1 inhibits lung adenocarcinoma invasion and tumor growth by repressing CXCL5 signaling.

Han N, Yuan X, Wu H, Xu H, Chu Q, Guo M, Yu S, Chen Y, Wu K. Han N, et al. Among authors: chu q. Oncotarget. 2015 Mar 20;6(8):5877-88. doi: 10.18632/oncotarget.3463. Oncotarget. 2015. PMID: 25788272 Free PMC article.

5

Meta-analysis reveals the correlation of Notch signaling with non-small cell lung cancer progression and prognosis.

Yuan X, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: chu q. Sci Rep. 2015 May 21;5:10338. doi: 10.1038/srep10338. Sci Rep. 2015. PMID: 25996086 Free PMC article.

6

Expression of Notch1 Correlates with Breast Cancer Progression and Prognosis.

Yuan X, Zhang M, Wu H, Xu H, Han N, Chu Q, Yu S, Chen Y, Wu K. Yuan X, et al. Among authors: chu q. PLoS One. 2015 Jun 29;10(6):e0131689. doi: 10.1371/journal.pone.0131689. eCollection 2015. PLoS One. 2015. PMID: 26121683 Free PMC article.

7

Notch signaling: an emerging therapeutic target for cancer treatment.

Yuan X, Wu H, Xu H, Xiong H, Chu Q, Yu S, Wu GS, Wu K. Yuan X, et al. Among authors: chu q. Cancer Lett. 2015 Dec 1;369(1):20-7. doi: 10.1016/j.canlet.2015.07.048. Epub 2015 Sep 1. Cancer Lett. 2015. PMID: 26341688 Free article. Review.

8

Emerging roles of Nrf2 signal in non-small cell lung cancer.

Tian Y, Liu Q, He X, Yuan X, Chen Y, Chu Q, Wu K. Tian Y, et al. Among authors: chu q. J Hematol Oncol. 2016 Feb 27;9:14. doi: 10.1186/s13045-016-0246-5. J Hematol Oncol. 2016. PMID: 26922479 Free PMC article. Review.

9

A novel paclitaxel-loaded poly(d,l-lactide-co-glycolide)-Tween 80 copolymer nanoparticle overcoming multidrug resistance for lung cancer treatment.

Yuan X, Ji W, Chen S, Bao Y, Tan S, Lu S, Wu K, Chu Q. Yuan X, et al. Among authors: chu q. Int J Nanomedicine. 2016 May 25;11:2119-31. doi: 10.2147/IJN.S92271. eCollection 2016. Int J Nanomedicine. 2016. PMID: 27307727 Free PMC article.

10

Modification of platinum sensitivity by KEAP1/NRF2 signals in non-small cell lung cancer.

Tian Y, Wu K, Liu Q, Han N, Zhang L, Chu Q, Chen Y. Tian Y, et al. Among authors: chu q. J Hematol Oncol. 2016 Sep 6;9(1):83. doi: 10.1186/s13045-016-0311-0. J Hematol Oncol. 2016. PMID: 27601007 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,379 results

Search Page